Dr. Dino Ferrante, MD

Dr. Ferrante practices at Madison Surgery Center in Madison, Alabama.

Dr. Ferrante's NPI, 1104815471, was assigned on October 19, 2005. Dr. Ferrante graduated from Heersink School of Medicine - Birmingham in 1995. Dr. Ferrante's Alabama license number on file is MD.20159.

Dr. Ferrante's primary practice is Madison Surgery Center, at 460 Lanier Road, Madison, AL 35758. The practice phone is (256) 319-9000.

Dr. Ferrante's primary practice is Madison Surgery Center in Madison, Alabama. Dr. Ferrante is also affiliated with Huntsville Hospital. The medical group on file is Center for Colon & Digestive Disease. Dmand AI also links Dr. Ferrante to 4 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ferrante practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ferrante's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ferrante is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Ferrante has a license on file in Alabama.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Ferrante treats.

CMS data shows 4,966 Medicare services from Dr. Ferrante across 23 procedure codes in 2024, for 858 Medicare patients. Medicare paid $174,711 for them.

CMS counts 858 Medicare patients who saw Dr. Ferrante in 2024. The largest group is 65 to 74, with 474 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ferrante's median patient age at 65, with 58% women.

In 2024, Dr. Ferrante wrote 2,660 Medicare Part D claims for 720 patients. 82% of them were for generic drugs. CMS names the drug for 2,472 of them, across 41 drugs with 11 or more claims each, at $899,878 in total drug cost. In 2023, CMS named 2,173 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 59 out of 100 for Dr. Ferrante for performance year 2024, reported as part of a group. Dr. Ferrante accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 371 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ferrante, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Ferrante. The most frequent topics are Reoperation. Dr. Ferrante has published most often in Am J Gastroenterol. Dr. Ferrante's most frequent co-author is Robert J. Cerfolio, MD.

CMS Open Payments shows 1,267 general payments to Dr. Ferrante from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $4,702.

Dmand AI lists 1 award for Dr. Ferrante, most recently CMS Stage 1 EHR in 2013.

Dr. Ferrante graduated from Heersink School of Medicine - Birmingham in 1995.

Dr. Ferrante is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.